SRF ID :0707904427971

PO No :PO1227871789-52

Name : Mr.SHREYASH TIWARI Order ID : 4416922

Age/Gender : 32/Male Registration Date : 20-Jan-23 02:45 PM
Patient ID : MLM76570 Collection Date : 20-Jan-23 02:50 PM
Barcode ID : A6869282 Sample Receive Date : 20-Jan-23 04:30 PM
Referred By : Dr. Report Status : Final Report
Sample Type : ORAL AND NASOPHARYNGEAL SWAB Report Date : 20-Jan-2023 08:23PM

Molecular Biology
Test Name Result Unit Bio. Ref. Range Method
SARS-CoV-2 RT PCR (Qualitative)
SARS-CoV2 RT PCR NEGATIVE RT PCR

Comment:

ICMR Registration Number : 1MGTPLGH

Methodology -
Qualitative RT PCR.

Clinical Significance:
This test is used for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a positive-sense, single-stranded RNA virus that causes coronavirus
disease 2019 (COVID-19). SARS-CoV-2 transmission occurs primarily via respiratory droplets.
The most common symptoms of COVID-19 are fever, tiredness, and dry cough. Some patients may have aches and pains, nasal
congestion, runny nose, sore throat or diarrhea. These symptoms are usually mild and begin gradually. Some people become infected
but don’t develop any symptoms and don't feel unwell. Most people recover from the disease without needing special treatment. Few
people who gets COVID-19 becomes seriously ill and develops difficulty breathing. Older people, and those with underlying medical
problems like high blood pressure, heart problems or diabetes,are more likely to develop serious illness.

Upper respiratory specimens ( e.g., Nasopharynx, oropharynx) are usually adequate for testing early-stage infections, especially in
asymptomatic or mild cases.
Lower respiratory specimens (eg, sputum, tracheal aspirate, bronchoalveolar fluid) are advised if collected later in the course of the
COVID-19 disease or in patients with a negative upper respiratory tract sampling and there is a strong clinical suspicion of COVID-19.

Limitations :
Improper collection, storage or transport of specimens may lead to false negative or invalid results.
Test results should be interpreted in conjunction with the patient’s medical history, clinical signs and symptoms, and the results of other
diagnostic tests performed.
Negative results do not rule out SARS-CoV-2 infections and should not be used as the sole basis for patient management decisions.
Detection of SARS-CoV-2 RNA may be affected by sample collection methods, patient factors (e.g., presence of symptoms), and/or
stage of infection.
False negative or invalid results may occur due to interference or the presence of inhibitors. The Internal Control is included to help
identify the specimens containing interfering substances or inhibitors.
This is a qualitative test and is not indicative of the quantity of virus in the sample.
False negative results may occur if viruses are present at levels below the test’s limit of detection.
False negative results may occur if mutations are present in the regions targeted by the test.
A potentialy reduced sensitivity may occur when viral concentrations are at or near the limit of detection of the assay.
Analyte targets (viral nucleic acid) may persist in vivo, independent of virus viability. Detection of analyte targets does not imply that

Kindly correlate clinically

Results relate only to the sample, as received

Page 1 of 2
 SRF ID :0707904427951
PO No :PO1227871375-52

Name : Mr.SHREYASH TIWARI Order ID : 4416875

Age/Gender : 31/Male Registration Date : 03-Apr-22 10:06 AM
Patient ID : MLM76570 Collection Date : 03/Apr/2022 09:35AM
Barcode ID : A6861287 Sample Receive Date : 03/Apr/2022 11:01AM
Referred By : Dr. Report Status : Final Report
Sample Type : ORAL AND NASOPHARYNGEAL SWAB Report Date : 03/Apr/2022 03:23PM

Molecular Biology
Test Name Result Unit Bio. Ref. Range Method
the corresponding viruses are infectious, or are the causative agents for clinical symptoms.

Interpretation Guidelines:
E Gene - It is common for Serbecovirus family of viruses, it’s detection in absence of RdRp/N Gene requires further testing.
RdRp and N Gene - These genes are confirmatory for SARS-CoV-2.

Note: It is not recommended to rely on numerical Ct values for determining infectiousness of COVID-19 patients and deciding patient
management protocols

*** End Of Report ***

Kindly correlate clinically

Results relate only to the sample, as received

Page 2 of 2
 TATA \mg Technologies Private Limited ’ Loe›oro Stezb Ofii4e-
oil @T TATA TFngI LoOs 82/A, Second Leva4 VO6ont SqUoye Mail
Pbone No 24 4006767 ^°°° ^@9 ° ’^' •^^ Pocket v sects e.
CAN: U74140DL2015PTCZ79Zg9

Conditions of laboratory Testing & Reporting:

• Test result reJeased pertain to the sample, as received

• Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be
clinically correlated by the interpreting Clinician.
• Result delays may happen because of unforeseen or uncontrollable circumstances.
e Test report may vary depending on the assay method used
• Test results may show inter-laboratory variations
• Test results are not valid for medico-legal purposes
e Please mail your queries related to test results to Customer Care mail id cs labsl 1 me com .

ResuJts relare only ro the sample received. Refer ro conditions ol reporting overleaf. Test Results marked "BOLD” indicates Abno rmo I
results i.e. higher or lower than normo I & The test morked with ( - ) were outsourceo to our partner To D. 4lI I.ob results ore subject to
clinical interpretotion Dy a qualified medical professional 6 This repo rt is not subject to use for o ny medico— legal purpose.